Srinivas Halthore
Neurology with Special Qualifications in Child Neurology · Allentown, PANPI 1730119413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,801 and has fallen 98.7% since, to $23 in 2025.
Across 166 payments — averaging $28.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Livanova USA, Inc.$626
- Neurelis, Inc.$405
- Sarepta Therapeutics, Inc.$383
- Acadia Pharmaceuticals Inc$304
- Jazz Pharmaceuticals Inc.$294
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,780100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 30 | $1,021 |
| Livanova USA, Inc. | 10 | $626 |
| Neurelis, Inc. | 14 | $405 |
| Sarepta Therapeutics, Inc. | 11 | $383 |
| Acadia Pharmaceuticals Inc | 16 | $304 |
| Jazz Pharmaceuticals Inc. | 10 | $294 |
| PTC Therapeutics, Inc. | 11 | $253 |
| Biogen | 5 | $210 |
| Genentech USA, Inc. | 7 | $160 |
| NS Pharma, Inc. | 5 | $152 |
| Ipsen Biopharmaceuticals, Inc | 6 | $137 |
| EMD Serono, Inc. | 3 | $107 |
| Amgen | 4 | $95 |
| AstraZeneca | 4 | $75 |
| Ironshore Pharmaceuticals Inc. | 3 | $70 |
| Immedica Pharma US, Inc. | 2 | $69 |
| Mallinckrodt Enterprises LLC | 3 | $52 |
| Biomarin Pharmaceutical Inc. | 3 | $44 |
| SK Life Science, Inc. | 1 | $37 |
| Merz Pharmaceuticals, LLC | 1 | $34 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| Catalyst Pharmaceuticals, Inc. | 2 | $31 |
| Eisai Inc. | 2 | $29 |
| Novartis | 1 | $26 |
| Biocodex, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Cranial Technologies, Inc | 1 | $20 |
| Greenwich Biosciences, Inc. | 1 | $15 |
| Saol Therapeutics Inc. | 1 | $15 |
| Aquestive Therapeutics, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 2 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$428
- Fintepla$230
- VALTOCO$130
- SPINRAZA$125
How this compares
$4,782 in reported general payments places this provider in the 65th percentile of 83 neurology with special qualifications in child neurology providers in Pennsylvania.
See all neurology with special qualifications in child neurology providers in Pennsylvania →
Other neurology with special qualifications in child neurology in Allentown
- Boosara RatanawongsaAllentown$6K
- Muhammed SheikhAllentown$2K
- Anne MorseDanville$582K
- John BrandsemaPhiladelphia$526K
- Susan MatesanzPhiladelphia$138K
- Elizabeth KichulaPhiladelphia$90K
- Dennis DlugosPhiladelphia$88K
- Alexandra KornbluhPhiladelphia$88K
- Nicholas AbendPhiladelphia$56K
- Sabrina YumPhiladelphia$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.